Takeda Fails In Bid To Avoid IBS Drug Antitrust Trial
By Bryan Koenig · October 30, 2025, 6:41 PM EDT
A Massachusetts federal judge has teed up Takeda Pharmaceutical for trial next year on claims from health insurers, self-insured employers, retailers and wholesalers accusing it of paying Par Pharmaceuticals to delay...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login